Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00089258
First received: August 4, 2004
Last updated: January 15, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)